{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:48:27Z","timestamp":1771627707331,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10549-020-05690-7","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T16:04:50Z","timestamp":1589904290000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?"],"prefix":"10.1007","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-1106","authenticated-orcid":false,"given":"Saed","family":"Ramzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erum","family":"Najeeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Coulthard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"issue":"1","key":"5690_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan ME et al (2011) Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 260(1):119\u2013128. https:\/\/doi.org\/10.1148\/radiol.11102368","journal-title":"Radiology"},{"issue":"4","key":"5690_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.5858\/arpa.2012-0078-RA","volume":"137","author":"KP Siziopikou","year":"2013","unstructured":"Siziopikou KP (2013) Ductal carcinoma in situ of the breast: current concepts and future directions. Arch Pathol Lab Med 137(4):462\u2013466. https:\/\/doi.org\/10.5858\/arpa.2012-0078-RA","journal-title":"Arch Pathol Lab Med"},{"key":"5690_CR3","unstructured":"Cancer Research UK (2020) In situ breast carcinoma incidence statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/incidence-in-situ#heading-Two. Accessed 21 Apr 2020"},{"key":"5690_CR4","unstructured":"Public Health England (2018) NHS breast screening (BSP) programme. https:\/\/www.gov.uk\/guidance\/breast-screening-programme-overview. Accessed 12 Apr 2020"},{"key":"5690_CR5","unstructured":"NHS Breast Screening Programme (2019) AgeX trial. https:\/\/www.agex.uk\/. Accessed 12 Apr 2020"},{"issue":"2","key":"5690_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/SLA.0b013e31815b446b","volume":"247","author":"M Intra","year":"2008","unstructured":"Intra M et al (2008) Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg 247(2):315\u2013319. https:\/\/doi.org\/10.1097\/SLA.0b013e31815b446b","journal-title":"Ann Surg"},{"issue":"2","key":"5690_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiology.218.2.r01fe35497","volume":"218","author":"RJ Jackman","year":"2001","unstructured":"Jackman RJ et al (2001) Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218(2):497\u2013502. https:\/\/doi.org\/10.1148\/radiology.218.2.r01fe35497","journal-title":"Radiology"},{"issue":"13","key":"5690_CR8","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1245\/s10434-015-4547-7","volume":"22","author":"AM Francis","year":"2015","unstructured":"Francis AM et al (2015) Is sentinel lymph node dissection warranted for patients with a diagnosis of ductal carcinoma in situ? Ann Surg Oncol 22(13):4270\u20134279. https:\/\/doi.org\/10.1245\/s10434-015-4547-7","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"5690_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10549-016-3783-2","volume":"156","author":"LM van Roozendaal","year":"2016","unstructured":"van Roozendaal LM et al (2016) Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Res Treat 156(3):517\u2013525. https:\/\/doi.org\/10.1007\/s10549-016-3783-2","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5690_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","volume":"98","author":"A Goyal","year":"2006","unstructured":"Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE (2006) Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat 98(3):311\u2013314. https:\/\/doi.org\/10.1007\/s10549-006-9167-2","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"5690_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.amjsurg.2005.06.011","volume":"190","author":"C Wilkie","year":"2005","unstructured":"Wilkie C, White L, Dupont E, Cantor A, Cox CE (2005) An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190(4):563\u2013566. https:\/\/doi.org\/10.1016\/j.amjsurg.2005.06.011","journal-title":"Am J Surg"},{"issue":"4","key":"5690_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","volume":"200","author":"TW Yen","year":"2005","unstructured":"Yen TW et al (2005) Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200(4):516\u2013526. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2004.11.012","journal-title":"J Am Coll Surg"},{"issue":"6","key":"5690_CR13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/000313480106700604","volume":"67","author":"CE Cox","year":"2001","unstructured":"Cox CE et al (2001) Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67(6):513\u2013519 discussion 519\u201321","journal-title":"Am Surg"},{"issue":"3","key":"5690_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.breast.2015.01.004","volume":"24","author":"S Prendeville","year":"2015","unstructured":"Prendeville S et al (2015) Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast. Breast 24(3):197\u2013200. https:\/\/doi.org\/10.1016\/j.breast.2015.01.004","journal-title":"Breast"},{"issue":"7","key":"5690_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1245\/ASO.2003.11.011","volume":"10","author":"LE Hoorntje","year":"2003","unstructured":"Hoorntje LE, Schipper ME, Peeters PH, Bellot F, Storm RK, Borel Rinkes IH (2003) The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 10(7):748\u2013753","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"5690_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/bjs.5735","volume":"94","author":"P Meijnen","year":"2007","unstructured":"Meijnen P, Oldenburg HS, Loo CE, Nieweg OE, Peterse JL, Rutgers EJ (2007) Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Br J Surg 94(8):952\u2013956. https:\/\/doi.org\/10.1002\/bjs.5735","journal-title":"Br J Surg"},{"issue":"10","key":"5690_CR17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1177\/000313481608201027","volume":"82","author":"V Bonev","year":"2016","unstructured":"Bonev V et al (2016) Is sentinel lymph node dissection necessary in all patients with ductal carcinoma in situ undergoing total mastectomy? Am Surg 82(10):982\u2013984","journal-title":"Am Surg"},{"issue":"7","key":"5690_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jso.20445","volume":"93","author":"MF Dillon","year":"2006","unstructured":"Dillon MF, McDermott EW, Quinn CM, O'Doherty A, O'Higgins N, Hill AD (2006) Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol 93(7):559\u2013563. https:\/\/doi.org\/10.1002\/jso.20445","journal-title":"J Surg Oncol"},{"issue":"2","key":"5690_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cursur.2004.09.011","volume":"62","author":"EA Mittendorf","year":"2005","unstructured":"Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD (2005) Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 62(2):253\u2013257. https:\/\/doi.org\/10.1016\/j.cursur.2004.09.011","journal-title":"Curr Surg"},{"issue":"2","key":"5690_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1148\/radiology.217.2.r00nv08466","volume":"217","author":"CH Lee","year":"2000","unstructured":"Lee CH et al (2000) Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology 217(2):466\u2013470. https:\/\/doi.org\/10.1148\/radiology.217.2.r00nv08466","journal-title":"Radiology"},{"issue":"5","key":"5690_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ejso.2014.02.095","volume":"40","author":"A Conway","year":"2014","unstructured":"Conway A, Rustom C, Wills R, Ball A, Stacey-Clear A, Waheed S (2014) Is sentinel node biopsy necessary in patients undergoing mastectomy for DCIS? Eur J Surg Oncol 40(5):638","journal-title":"Eur J Surg Oncol"},{"key":"5690_CR22","doi-asserted-by":"publisher","first-page":"394095","DOI":"10.5402\/2012\/394095","volume":"2012","author":"DE Boler","year":"2012","unstructured":"Boler DE, Cabioglu N, Ince U, Esen G, Uras C (2012) Sentinel lymph node biopsy in pure DCIS: is it necessary? ISRN Surg 2012:394095. https:\/\/doi.org\/10.5402\/2012\/394095","journal-title":"ISRN Surg"},{"issue":"3","key":"5690_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.clon.2008.12.008","volume":"21","author":"J Yarnold","year":"2009","unstructured":"Yarnold J (2009) Early and locally advanced breast cancer: diagnosis and treatment National Institute for Health and Clinical Excellence guideline 2009. Clin Oncol 21(3):159\u2013160","journal-title":"Clin Oncol"},{"key":"5690_CR24","unstructured":"National Comprehensive Cancer Network. Breast Cancer (Version 3.2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed 12 Apr 2020"},{"issue":"22","key":"5690_CR25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.21037\/atm.2019.11.106","volume":"7","author":"Z He","year":"2019","unstructured":"He Z et al (2019) Clinical value of postoperative sentinel lymph node biopsy. Ann Transl Med 7(22):683","journal-title":"Ann Transl Med"},{"issue":"4","key":"5690_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.remn.2011.03.005","volume":"30","author":"I Blanco","year":"2011","unstructured":"Blanco I et al (2011) Sentinel node biopsy in patients with breast cancer and previous breast surgery. Rev Esp Med Nucl 30(4):223\u2013228. https:\/\/doi.org\/10.1016\/j.remn.2011.03.005","journal-title":"Rev Esp Med Nucl"},{"key":"5690_CR27","unstructured":"Cancer Australia. Breast cancer (10\/12\/2018). https:\/\/breast-cancer.canceraustralia.gov.au\/treatment\/ductal-carcinoma-situ#DCIS%20lymph. Accessed 12 Apr 2020"},{"issue":"1","key":"5690_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1245\/s10434-014-3928-7","volume":"22","author":"N Wetzig","year":"2015","unstructured":"Wetzig N et al (2015) Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial. Ann Surg Oncol 22(1):17\u201323. https:\/\/doi.org\/10.1245\/s10434-014-3928-7","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5690_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.21535","volume":"102","author":"T Ashikaga","year":"2010","unstructured":"Ashikaga T et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102(2):111\u2013118. https:\/\/doi.org\/10.1002\/jso.21535","journal-title":"J Surg Oncol"},{"issue":"2","key":"5690_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","volume":"247","author":"G Zavagno","year":"2008","unstructured":"Zavagno G et al (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella\/GIVOM trial. Ann Surg 247(2):207\u2013213. https:\/\/doi.org\/10.1097\/SLA.0b013e31812e6a73","journal-title":"Ann Surg"},{"issue":"9","key":"5690_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599\u2013609","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5690_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/bjc.2012.62","volume":"106","author":"H Verry","year":"2012","unstructured":"Verry H et al (2012) Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. Br J Cancer 106(6):1045\u20131052. https:\/\/doi.org\/10.1038\/bjc.2012.62","journal-title":"Br J Cancer"},{"key":"5690_CR33","unstructured":"Ellis I et al (2005) Pathology reporting of breast disease. NHS Publication No 58. Sheffield, NHS cancer screening programmes and the royal college of pathologists"},{"key":"5690_CR34","unstructured":"Ellis I et al (2016) Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer"},{"issue":"6","key":"5690_CR35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ejca.2007.01.010","volume":"43","author":"CH van Deurzen","year":"2007","unstructured":"van Deurzen CH, Hobbelink MG, van Hillegersberg R, van Diest PJ (2007) Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. Eur J Cancer 43(6):993\u20131001. https:\/\/doi.org\/10.1016\/j.ejca.2007.01.010","journal-title":"Eur J Cancer"},{"issue":"7","key":"5690_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ejso.2006.04.019","volume":"32","author":"J Mathew","year":"2006","unstructured":"Mathew J, Barthelmes L, Neminathan S, Crawford D (2006) Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery. Eur J Surg Oncol (EJSO) 32(7):729\u2013732","journal-title":"Eur J Surg Oncol (EJSO)"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05690-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05690-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05690-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T08:32:25Z","timestamp":1696149145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05690-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5690"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05690-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"8 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}